FDA Inspection
ONY Biotech, Inc.ONY Biotech, Inc. – FDA Inspection, Feb 5, 2026
Record Details
This FDA Inspection record concerns ONY Biotech, Inc., with an inspection on February 5, 2026, issued by the New York District Office, covering human drugs.
View Company Profile
ID · 1a72f1f8-4ab4-4eb7-8fc5-58ded428e2b7
Inspection Facts
- Inspection number
- 1301388
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ONY Biotech, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 26, 2024 | OAI | New York District Office | Drug Quality Assurance |
| March 2, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 9, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 25, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 6, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ONY Biotech, Inc.
- FDA Inspection 1250105 - 2024-09-26
- FDA Inspection 1005033 - 2017-03-02
- FDA Inspection 946338 - 2015-10-09
- FDA Inspection 830440 - 2013-04-25
- FDA Inspection 748464 - 2011-10-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.